Scroll To Top
News

Microbicide News

Microbicide News

Coverx100_528

The United Kingdom's Microbicide Development Programme has announced the launch of a 39-month Phase III clinical trial of PRO 2000, a microbicide developed by Indevus Pharmaceuticals. The gel will be tested to determine its effects in blocking HIV and other sexually transmitted diseases among 10,000 women in Uganda, Tanzania, South Africa, and Zambia. '''''''''' About 200 men and women in Australia and Thailand are being recruited to participate in a Phase I safety trial of VivaGel, a microbicide that aims to prevent HIV and herpes infections. Lab studies showed the compound binds to a protein on the surface of HIV, blocking it from infecting human cells.

Advocate Channel - The Pride StoreOut Magazine - Fellow Travelers

From our Sponsors

Most Popular

Latest Stories

Plus Editors

Editor

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.

Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.